| SpectraBase Spectrum ID |
GYSfjXfw3u4 |
| Name |
5-APDI N-(4-bromobenzyl) |
| Classification |
Amphetamine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
343.093562712 u |
| Formula |
C19H22BrN |
| InChI |
InChI=1S/C19H22BrN/c1-14(21-13-15-6-9-19(20)10-7-15)11-16-5-8-17-3-2-4-18(17)12-16/h5-10,12,14,21H,2-4,11,13H2,1H3 |
| InChIKey |
YSXLEQAMJKYTJQ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
344.296 g/mol |
| Nominal Mass |
343 u |
| Quality |
987 |
| Retention Index |
2457 |
| SMILES |
C=12C(=CC(CC(NCC=3C=CC(=CC3)Br)C)=CC1)CCC2 |
| SPLASH |
splash10-03di-1890000000-cd36e66bbcfe453de76b |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N-4-Bromobenzyl-1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_021269 |
